AML |
acute myeloid leukaemia |
APCs |
antigen-presenting cells |
BCR |
B-cell receptor |
Bregs |
regulatory B cells |
CAF |
cancer-associated fibroblasts |
CRC |
colorectal cancer |
CSCs |
cancer stem cells |
CTLs |
cytotoxic T lymphocytes/CD8+ T lymphocytes/CD8+ T cells |
DAMPs |
damage-associated molecular patterns |
DCs |
dendritic cells |
ECM |
extracellular matrix |
EGF |
epidermal growth factor |
ICI |
immune checkpoint inhibitor |
IDO |
indoleamine 2,3-dioxygenase |
IFN |
Interferon |
IIC |
infiltrating immune cells |
IL |
Interleukin |
ILCs |
innate lymphoid cells |
IR |
immune response |
IS |
immune system |
LTis |
lymphoid-tissue inducer cells |
MCs |
mast cells |
MDSCs |
myeloid-derived suppressor cells |
MHC-I/-II |
major histocompatibility complex-I/-II |
NK cells |
natural killer cells |
NSCLC |
non-small-cell lung cancer |
PAMPs |
pathogen-associated molecular patterns |
PDAC |
pancreatic ductal adenocarcinoma |
PD-1 |
programmed cell death protein 1 |
PGE2 |
prostaglandin E2 |
ROS/RNS |
reactive oxygen species/reactive nitrogen species |
SCC |
squamous cell carcinoma |
TCR |
T-cell receptor |
TGF |
transforming growth factor |
Th |
T helper/CD4+ T lymphocytes/CD4+ T cells |
TIL B cells |
tumour-infiltrating B cells |
TLRs |
toll-like receptors |
TME |
tumour microenvironment |
TNF |
tumour necrosis factor |
Treg |
regulatory T cells |
VEGF |
endothelial growth factor |